AU2019902672A0 - Methods of treatment - Google Patents
Methods of treatmentInfo
- Publication number
- AU2019902672A0 AU2019902672A0 AU2019902672A AU2019902672A AU2019902672A0 AU 2019902672 A0 AU2019902672 A0 AU 2019902672A0 AU 2019902672 A AU2019902672 A AU 2019902672A AU 2019902672 A AU2019902672 A AU 2019902672A AU 2019902672 A0 AU2019902672 A0 AU 2019902672A0
- Authority
- AU
- Australia
- Prior art keywords
- treatment
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2020319701A AU2020319701A1 (en) | 2019-07-26 | 2020-07-24 | P2X7 receptor targeted therapy |
BR112022000142A BR112022000142A2 (en) | 2019-07-26 | 2020-07-24 | treatment methods |
CA3143419A CA3143419A1 (en) | 2019-07-26 | 2020-07-24 | P2x7 receptor targeted therapy |
JP2022505386A JP2022541344A (en) | 2019-07-26 | 2020-07-24 | Targeted therapy for P2X7 receptors |
PCT/GB2020/051791 WO2021019222A1 (en) | 2019-07-26 | 2020-07-24 | P2x7 receptor targeted therapy |
US17/618,849 US20220251187A1 (en) | 2019-07-26 | 2020-07-24 | P2x7 receptor targeted therapy |
MX2021015593A MX2021015593A (en) | 2019-07-26 | 2020-07-24 | P2x7 receptor targeted therapy. |
CN202080053631.3A CN114173811A (en) | 2019-07-26 | 2020-07-24 | P2X7 receptor targeted therapy |
EP20754010.5A EP4003531A1 (en) | 2019-07-26 | 2020-07-24 | P2x7 receptor targeted therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2019902672A0 true AU2019902672A0 (en) | 2019-08-08 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3426250A4 (en) | Methods of treatment | |
EP3893883A4 (en) | Methods for the treatment of depression | |
EP3684342A4 (en) | Method of treatment | |
EP3630101A4 (en) | Methods for treatment of fibrotic diseases | |
EP3735209A4 (en) | Treatment of myopic progression | |
EP3937964A4 (en) | Treatment of oncogene-driven cancers | |
EP3856207A4 (en) | Treatment methods | |
EP3856241A4 (en) | Treatment methods | |
EP3890780A4 (en) | Method of treatment | |
EP4017493A4 (en) | Methods of treatment using bcn057 and bcn512 | |
EP3727376A4 (en) | Methods of treatment of hypertrigl yceridemia | |
EP4065573A4 (en) | Methods of treatment | |
EP4025218A4 (en) | Methods of treatment | |
AU2019903451A0 (en) | Methods of treatment | |
AU2019902672A0 (en) | Methods of treatment | |
EP3979789A4 (en) | Treatment of saprolegniasis | |
AU2019903303A0 (en) | Method of Treatment | |
EP4034125A4 (en) | Treatment of excitotoxicity-related conditions | |
AU2019901742A0 (en) | Method of treatment | |
AU2019901280A0 (en) | Method of Treatment | |
AU2019900339A0 (en) | Method of Treatment | |
AU2019903588A0 (en) | Treatment of excitotoxicity-related conditions | |
AU2018904581A0 (en) | Method of treatment | |
AU2018901775A0 (en) | Method of treatment | |
AU2019900337A0 (en) | Treatment Methods |